Atezolizumab Immunotherapy in Patients With Advanced NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Helen Ross, MD
Mayo Clinic
Study Chair - Monica Bertagnolli, MD
Alliance Foundation Trials
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Hospital
Phoenix, Arizona, United States
- Ucsd Moores Cancer Center
La Jolla, California, United States
- the University of Chicago Medical Center
Chicago, Illinois, United States
- Emmc Cancer Care
Brewer, Maine, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Metro Mn Community Oncology Research Consortium
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Ohio State University James Cancer Center
Columbus, Ohio, United States
- Lankenau Medical Center
Wynnewood, Pennsylvania, United States
- Prisma Health Greenville Memorial Hospital
Greenville, South Carolina, United States
- University of Virginia Cancer Center
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2017
- Primary completion
- 1 Jun 2020
- Completion
- 1 Oct 2022
- Last update posted
- 24 May 2023
- Registered enrollment
- 64
- Registry id
- NCT03102242
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.